Keywords: appeal, novartis, overturn, india, patent, law, glivec
Appeal to Novartis not to overturn India's patent law with Glivec action
Article | 23 October 2006
Switzerland-based medical and non-governmental organizations (NGOs) have called on domestic pharmaceutical giant Novartis to stop legal action, filed in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
